tirzepatide cause cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Does Mounjaro increase the risk

Protocol B: Low Maintenance (0.25 mg indefinite) This is the most conservative approach and stays within studied dose ranges during the taper

Many people understand this, but they often think that this means sticking to a rigid, unpleasant, and boring diet

But adding it to injected insulin changes the equation

Although GLP-1 medications like Ozempic are highly effective, individual results can vary based on factors such as dosage, patient adherence, lifestyle modifications like diet and exercise, and personal health conditions

Monitoring GGT levels helps detect and track diseases like atherosclerosis, autoimmune disorders, infections, cancer, and organ damage